NOS1 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Finally, our study additionally suggests that, at the cardiomyocyte level, the regulation of Ca2+ handling via the beta-adrenergic pathway and via nNOS activity is not impaired by dystrophin deficiency.